Clinical Trials Browser

Phase 1/2 × NSCLC × Pemetrexed × Clear all

NCT05636267 2026-03-09

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

Phase 1/2 Terminated

NSCLC